Damien Logeart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Damien Logeart has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Jacques Mercadier
Inserm U. 460, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri Huchard, 75018 Paris, France
3 shared publications Alain Cohen Solal
2 shared publicationsGabriel Thabut
2 shared publicationsJean-Baptiste Michel
2 shared publicationsJean-Yves Tabet
2 shared publications- Marc Sirol
AP HP – Hopital Lariboisiere, Cardiologie, Paris, France
2 shared publications
Latest Publications
- 1 January 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (1) , 41
0437: Impact of RV involvement on LV remodeling after acute MI
- 1 January 2016
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 8 (1) , 41
0437: Impact of RV involvement on LV remodeling after acute MI
- 1 July 2008
- Published by Elsevier in International Journal of Cardiology
- Vol. 127 (2) , 228-232
Transient worsening of renal function during hospitalization for acute heart failure alters outcome
- 1 July 2008
- Published by Elsevier in International Journal of Cardiology
- Vol. 127 (2) , 228-232
Transient worsening of renal function during hospitalization for acute heart failure alters outcome
- 13 December 2006
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (2) , 286-292
Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism
Objective To evaluate the usefulness of B-type natriuretic peptide and troponin I measurements in predicting right ventricular dysfunction (RVD) in non-massive pulmonary embolism. Design Prospective observational study. Setting University-affiliated emergency unit, cardiology and pneumology departments. Patients Sixty-seven patients admitted because of acute pulmonary embolism, without shock on admission, completed the study. Interventions Blood samples and echocardiography were obtained on admission for subsequent and independent assessment of B-type natriuretic peptide (BNP) and troponin I levels as well as RVD. Measurements and results Echocardiographic RVD was diagnosed in 36 patients and was severe in 13 on admission. BNP and troponin I levels were higher in patients with RVD than in those with no RVD [62 (27–105) vs. 431 (289–556) pg/ml for BNP, p < 0.001; 0.01 (0–0.09) vs. 0.16 (0.03–0.32) μg/l for troponin I, p = 0.005]. The area under the receiving operating characteristic curve (AUC) for diagnosing RVD was 0.93 for BNP and 0.72 for troponin I. The troponin I level increased further when RVD was severe, compared with moderate, and the AUC was 0.91 for identifying severe RVD. Diagnoses of RVD and severe RVD were ruled out by BNP ≤ 100 pg/ml (30% of patients) and troponin I 0.10 μg/l (58% of patients), respectively. In-hospital death or circulatory failure occurred in nine patients; all had echographic RVD and level of BNP > 100 pg/ml and troponin I > 0.10 μg/l. Conclusion In hemodynamically stable pulmonary embolism, BNP/troponin I measurement is helpful on admission, especially for ruling out RVD, i. e. patients with in-hospital high-risk.
- 13 December 2006
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (2) , 286-292
Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism
Objective To evaluate the usefulness of B-type natriuretic peptide and troponin I measurements in predicting right ventricular dysfunction (RVD) in non-massive pulmonary embolism. Design Prospective observational study. Setting University-affiliated emergency unit, cardiology and pneumology departments. Patients Sixty-seven patients admitted because of acute pulmonary embolism, without shock on admission, completed the study. Interventions Blood samples and echocardiography were obtained on admission for subsequent and independent assessment of B-type natriuretic peptide (BNP) and troponin I levels as well as RVD. Measurements and results Echocardiographic RVD was diagnosed in 36 patients and was severe in 13 on admission. BNP and troponin I levels were higher in patients with RVD than in those with no RVD [62 (27–105) vs. 431 (289–556) pg/ml for BNP, p < 0.001; 0.01 (0–0.09) vs. 0.16 (0.03–0.32) μg/l for troponin I, p = 0.005]. The area under the receiving operating characteristic curve (AUC) for diagnosing RVD was 0.93 for BNP and 0.72 for troponin I. The troponin I level increased further when RVD was severe, compared with moderate, and the AUC was 0.91 for identifying severe RVD. Diagnoses of RVD and severe RVD were ruled out by BNP ≤ 100 pg/ml (30% of patients) and troponin I 0.10 μg/l (58% of patients), respectively. In-hospital death or circulatory failure occurred in nine patients; all had echographic RVD and level of BNP > 100 pg/ml and troponin I > 0.10 μg/l. Conclusion In hemodynamically stable pulmonary embolism, BNP/troponin I measurement is helpful on admission, especially for ruling out RVD, i. e. patients with in-hospital high-risk.
- Open Access
- 1 October 2006
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 291 (4) , H1773-H1779
Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study
The aim of this study was to examine the efficiency of adenovirus-mediated overexpression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1a) gene in a realistic model based on percutaneous intracoronary delivery and on noninvasive functional monitoring. Catheter-based selective coronary delivery of saline or adenoviruses (Ad.CMV.SERCA1a or Ad.CMV.lacZ, 1010plaque-forming units) was performed in the circumflex artery of rabbits. Effects were assessed and compared by using serial Doppler echocardiography, hemodynamics, and measurements of SERCA protein and Ca2+uptake activity. On day 3, a 21% increase in SERCA proteins and a 37% increase in the maximal rate of Ca2+uptake were observed in the transfected left ventricular (LV) walls of Ad.CMV.SERCA1a rabbits. Baseline hemodynamics and conventional echographic measurements of global LV function were poorly affected. In contrast, tissue Doppler imaging (TDI) was able to assess a strong increase in the baseline function of transfected LV walls, as assessed with maximal wall velocities (+32% and +43%, respectively) and strain rates (+18% and +30%, respectively). TDI parameters were closely related to the maximal rate of Ca2+uptake ( r2= 0.68 for the systolic strain rate). Serial TDI analysis during follow-up showed that the effects lasted for 7 days and were no longer detectable 15 days after adenoviruses injection. In conclusion, LV function can be increased by adenovirus-mediated overexpression of SERCA in a clinically relevant model, and TDI provides an accurate and noninvasive tool for monitoring effects on global as well as regional myocardial function.
- 1 October 2006
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 291 (4) , H1773-H1779
Open AccessPercutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study
The aim of this study was to examine the efficiency of adenovirus-mediated overexpression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1a) gene in a realistic model based on percutaneous intracoronary delivery and on noninvasive functional monitoring. Catheter-based selective coronary delivery of saline or adenoviruses (Ad.CMV.SERCA1a or Ad.CMV.lacZ, 1010plaque-forming units) was performed in the circumflex artery of rabbits. Effects were assessed and compared by using serial Doppler echocardiography, hemodynamics, and measurements of SERCA protein and Ca2+uptake activity. On day 3, a 21% increase in SERCA proteins and a 37% increase in the maximal rate of Ca2+uptake were observed in the transfected left ventricular (LV) walls of Ad.CMV.SERCA1a rabbits. Baseline hemodynamics and conventional echographic measurements of global LV function were poorly affected. In contrast, tissue Doppler imaging (TDI) was able to assess a strong increase in the baseline function of transfected LV walls, as assessed with maximal wall velocities (+32% and +43%, respectively) and strain rates (+18% and +30%, respectively). TDI parameters were closely related to the maximal rate of Ca2+uptake ( r2= 0.68 for the systolic strain rate). Serial TDI analysis during follow-up showed that the effects lasted for 7 days and were no longer detectable 15 days after adenoviruses injection. In conclusion, LV function can be increased by adenovirus-mediated overexpression of SERCA in a clinically relevant model, and TDI provides an accurate and noninvasive tool for monitoring effects on global as well as regional myocardial function.
- Open Access
- 15 June 2004
- Published by EDP Sciences in médecine/sciences
- Vol. 20 (6-7) , 643-650
Remodelage précoce du ventricule gauche après un accident coronarien aigu
Ventricular remodelling following acute coronary syndromes is both complex and multiform. It is due to the response of the myocardium to the different agressions associated with these syndromes, in particular the ischemia and necrosis downstream of the occluded artery. We must not however neglect the role of the remodelling of the lesions resulting from spontaneous reperfusion or provoked by the cells and tissues associated with coronary microcirculation embolisms and the no-reflow phenomenon. Acute post-infarct remodelling is dominated by early ventricular dilatation which largely affects late prognosis, necrosis elimination and its replacement by a fibrotic scar in parallel with a compensatory hypertrophy of the non-infarcted myocardium. The diverse cellular and molecular components of this remodelling are increasingly well-known, allowing us to better explain the beneficial effects of the currently available medications and providing us with new potential therapeutic targets. A grading of this knowledge associated with the identification of new risk factors and early therapeutic interventions should help us to further limit the deleterious aspects of this remodelling in the goal of preventing, or at least delaying, the devolution towards heart failure.
- 15 June 2004
- Published by EDP Sciences in médecine/sciences
- Vol. 20 (6-7) , 643-650
Open AccessRemodelage précoce du ventricule gauche après un accident coronarien aigu
Ventricular remodelling following acute coronary syndromes is both complex and multiform. It is due to the response of the myocardium to the different agressions associated with these syndromes, in particular the ischemia and necrosis downstream of the occluded artery. We must not however neglect the role of the remodelling of the lesions resulting from spontaneous reperfusion or provoked by the cells and tissues associated with coronary microcirculation embolisms and the no-reflow phenomenon. Acute post-infarct remodelling is dominated by early ventricular dilatation which largely affects late prognosis, necrosis elimination and its replacement by a fibrotic scar in parallel with a compensatory hypertrophy of the non-infarcted myocardium. The diverse cellular and molecular components of this remodelling are increasingly well-known, allowing us to better explain the beneficial effects of the currently available medications and providing us with new potential therapeutic targets. A grading of this knowledge associated with the identification of new risk factors and early therapeutic interventions should help us to further limit the deleterious aspects of this remodelling in the goal of preventing, or at least delaying, the devolution towards heart failure.